Back    Zoom +    Zoom -
<Research>M Stanley Largely Adds PA GOODDOCTOR TP to $16.3 as Synergy with PING AN Expands
Recommend
35
Positive
57
Negative
24
Morgan Stanley, in its report, said it was encouraged by the expanding and deepening synergies between PA GOODDOCTOR (01833.HK) and PING AN (02318.HK) in the "Financial" and "Business" channels, which were expected to manifest faster revenue growth. The integration of AI further supports margin expansion and is trending towards PA GOODDOCTOR's medium-term target of approximately 10%.

Morgan Stanley raised the target price for PA GOODDOCTOR from HKD7.5 to HKD16.3, and increased the adjusted EPS forecasts for 2025/ 2026/ 2027 by 13%/ 12%/ 11%. The rating was Equal-weight.

Related NewsJefferies Keeps Underperform on PA GOODDOCTOR, Raises TP to HKD5.9

AASTOCKS Financial News
Website: www.aastocks.com